Kacey Lyons
Adult Health · Houston, TXNPI 1598544777
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Phathom Pharmaceuticals, Inc. accounts for 86.1% of it on its own, with 17 other manufacturers making up the rest. Among adult health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $136.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Phathom Pharmaceuticals, Inc.$17K
- AbbVie$692
- Takeda Pharmaceuticals U.S.A., Inc.$379
- Madrigal Pharmaceuticals$367
- Johnson & Johnson$280
- Gilead$171
- plus $836 from 12 others
What the payments were for
- Speaking & faculty fees$10,18552%
- Travel & lodging$5,51628%
- Food & beverage$3,85020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 37 | $16,827 |
| AbbVie | 30 | $692 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $379 |
| Madrigal Pharmaceuticals | 9 | $367 |
| Johnson & Johnson | 9 | $280 |
| Gilead | 4 | $171 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $155 |
| Intercept Pharmaceuticals, Inc. | 8 | $147 |
| Organon | 7 | $137 |
| Novo Nordisk | 1 | $109 |
| Ardelyx, Inc. | 3 | $75 |
| Napo Pharmaceuticals Inc | 2 | $39 |
| Mirum Pharmaceuticals, Inc. | 1 | $34 |
| Evoke Pharma, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $33 |
| AstraZeneca | 1 | $32 |
| Merck | 1 | $21 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,551 in reported general payments places this provider in the 95th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 18 | $21,742 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 27 | $1,702 |
| Famotidine | 76 | $1,055 |
| Pantoprazole Sodium | 70 | $589 |
| Dicyclomine Hcl | 27 | $581 |
| Sucralfate | 28 | $580 |
| Omeprazole | 41 | $472 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $692 | $21,74218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 933 adult health providers in Texas.
Other adult health in Houston
- Rosa RancesHouston$17K
- Claressa RosacinaHouston$17K
- Michelle MartinHouston$15K
- Loren SemonesHouston$14K
- Anthony SantosHouston$13K
- Dashawn ThomasHouston$11K
- Zandra RiveraHouston$11K
- Brandy KhodrHouston$10K
- Janice TranHouston$10K
- Ester CerdanHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.